About Chugai
Chugai's mission is to create innovative drugs
for the benefit of patients.
News ReleasesRSS
- Nov 15, 2019 Chugai Wins Prize in 7th WICI Japan Award for Excellence in Integrated Reporting
- Nov 08, 2019 Chugai Files a New Drug Application for Satralizumab for NMOSD in Japan, Following the United States and Europe
- Nov 01, 2019 Chugai’s Hemlibra Launched for Hemophiia A with Inhibitors in Taiwan
- Oct 30, 2019 Chugai’s Hemlibra Approved for Hemophilia A without inhibitors in Taiwan
- Oct 30, 2019 EMA and FDA Accept Marketing Applications for Chugai's Satralizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)
-
Diversity and Inclusion Initiatives
Find information on our initiatives to promote work-life balance and diverse human resources, and performance data for topics such as the ratio of female employees.
-
Engagement with Employees
Chugai promotes engagement with employees by conducting talent management according to each person's capabilities and aptitude, providing systems that help our diverse people to succeed, and creating supportive work environments.
For more information
Feature: Chugai’s Sustainability Activities
Recent Social Contribution Activities
-
Biology Lab Classes for Children Held (2018)
-
Participating in the 48th Annual Cleaning of the Famed Nihonbashi Bridge
-
Chugai to Take Part in Relay for Life Japan 2018
